- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.17 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 8 x FLC: CITRATE ANION(Non-covalent)
- 1 x TAK: 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine(Non-covalent)
- 13 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.9: 5 residues within 4Å:- Chain A: F.262, D.264, Q.284, R.285, N.287
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.287
- Water bridges: A:F.262, A:N.287
EDO.10: 6 residues within 4Å:- Chain A: C.226, D.228, S.229, R.232, P.313, S.314
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.228, A:S.314
EDO.11: 5 residues within 4Å:- Chain A: E.91, K.176, N.178
- Ligands: FLC.3, FLC.4
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:E.91, A:K.176
- Water bridges: A:N.178
EDO.12: 2 residues within 4Å:- Chain A: T.133, D.295
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.133
EDO.13: 4 residues within 4Å:- Chain A: R.285, P.286, K.306, W.309
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:P.286
- Water bridges: A:I.288
EDO.14: 6 residues within 4Å:- Chain A: L.15, G.95, F.96, I.97, H.115
- Ligands: FLC.4
2 PLIP interactions:2 interactions with chain A- Water bridges: A:F.96, A:F.96
EDO.15: 3 residues within 4Å:- Chain A: R.33, R.37
- Chain B: Q.54
4 PLIP interactions:1 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:Q.54, A:R.33, A:R.37, A:R.37
EDO.16: 2 residues within 4Å:- Chain A: L.42, E.43
No protein-ligand interaction detected (PLIP)EDO.17: 3 residues within 4Å:- Chain A: N.62, Y.116, E.118
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.62
EDO.19: 4 residues within 4Å:- Chain B: L.31, Q.32, N.33, P.93
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.33
- Water bridges: B:Q.32
EDO.20: 4 residues within 4Å:- Chain A: T.34, Q.38
- Chain B: F.47, K.48
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:K.48, A:Q.38
- Water bridges: B:P.46
EDO.21: 6 residues within 4Å:- Chain B: P.10, G.11, G.13, F.16, S.68, Q.71
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:G.11, B:G.11, B:G.13, B:S.68, B:S.68
EDO.22: 3 residues within 4Å:- Chain B: I.51, G.52, E.61
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.61
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Williams, E. et al., Crystal Structure of Human Acvr1 (Alk2) in Complex with Fkbp12.6 And Dorsomorphin. Ph D Thesis
- Release Date
- 2013-08-07
- Peptides
- ACTIVIN RECEPTOR TYPE-1: A
PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.17 Å
- Oligo State
- hetero-1-1-mer
- Ligands
- 8 x FLC: CITRATE ANION(Non-covalent)
- 1 x TAK: 6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine(Non-covalent)
- 13 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Williams, E. et al., Crystal Structure of Human Acvr1 (Alk2) in Complex with Fkbp12.6 And Dorsomorphin. Ph D Thesis
- Release Date
- 2013-08-07
- Peptides
- ACTIVIN RECEPTOR TYPE-1: A
PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1B: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B